General MedicationsORALGeneric
RELA
CARISOPRODOL
Standard Dose
350MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview RELA is listed in Drugs@FDA under application 012155 (NDA).
Marketing status: Discontinued Active ingredient CARISOPRODOL Form and strength TABLET;ORAL - 350MG Sponsor SCHERING Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview RELA is listed in Drugs@FDA under application 012155 (NDA). Marketing status: Discontinued Active ingredient CARISOPRODOL Form and strength TABLET;ORAL - 350MG Sponsor SCHERING Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.